Leveraging Adipocyte-Cardiomyocyte Signaling to Treat Ischemic Heart Failure

Circ Res. 2022 Jul 8;131(2):165-167. doi: 10.1161/CIRCRESAHA.122.321392. Epub 2022 Jul 7.

Authors

Jake E Doiron^{1

2}, David J Lefer^{1

2}

Affiliations

¹ Cardiovascular Center of Excellence, School of Medicine, LSU Health Science Center, New Orleans, LA (J.E.D., D.J.L.).
² Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans (J.E.D., D.J.L.).

PMID: 35861740
DOI: 10.1161/CIRCRESAHA.122.321392

No abstract available

Keywords: cardiovascular disease; edema; heart failure; hospital; myocardial infarction.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Adipocytes
Heart Failure* / therapy
Humans
Myocardial Infarction*
Myocytes, Cardiac

Grants and funding